The escalating crisis of Type 2 Diabetes (T2D) in the United States is prompting a significant shift in treatment paradigms. Today, the American College of Lifestyle Medicine (ACLM) launched “Project Remission,” a national digital film series showcasing the power of lifestyle interventions to not just *manage*, but potentially *reverse* the disease. This initiative arrives at … Read more
The Weight Loss Revolution: Beyond GLP-1s, a New Era of Personalized Metabolic Health Nearly 42% of American adults are now considered obese, a figure that’s not just a public health crisis, but a rapidly evolving market. While injectable GLP-1 receptor agonists like Ozempic and Wegovy have dominated headlines, a quiet revolution is underway – one … Read more
Brown Fat Breakthrough: Could SLIT3 Protein Be the Key to Effortless Weight Management? Nearly 60% of adults worldwide are overweight or obese, a statistic driving a global health crisis. For decades, the focus has been on restricting calories and increasing exercise. But what if unlocking the body’s natural fat-burning capabilities offered a simpler, more sustainable … Read more
The widely-used Body Mass Index (BMI) is failing a significant portion of the population, leading to misdiagnosis of weight status and potentially impacting public health strategies. New research presented at the European Congress on Obesity (ECO 2026) and published in Nutrients demonstrates that the “gold standard” of body composition measurement – dual-energy X-ray absorptiometry (DXA) … Read more
The Shifting Landscape of Obesity Treatment: AI, Metabolism, and Personalized Care The fight against obesity is undergoing a radical transformation, moving beyond traditional diet and exercise recommendations towards a more nuanced understanding of individual metabolism and the integration of cutting-edge technologies like artificial intelligence. Recent advancements are challenging long-held beliefs about weight management, offering new … Read more
For years, a significant source of anxiety for women diagnosed with idiopathic intracranial hypertension (IIH) – a debilitating condition causing increased brain pressure – has been the potential link to hormonal contraception. Now, a comprehensive meta-analysis published in Neurology® offers a crucial reassurance: there’s no evidence to support that connection. This finding is particularly important … Read more
Medicare & Medicaid Expansion of GLP-1 Access: A New Era for Diabetes and Weight Management February 29, 2024 Washington D.C. – Access to glucagon-like peptide-1 (GLP-1) receptor agonists, a class of drugs initially developed for type 2 diabetes but increasingly used for weight management, is undergoing a significant shift within Medicare and Medicaid. The Centers … Read more
The race to conquer obesity is entering a new phase, one where simply shedding pounds isn’t enough. Swedish biotech Atrogi has begun dosing subjects in a human trial for ATR-258, a novel drug candidate aiming to tackle a critical, often overlooked consequence of weight loss: muscle loss. This isn’t just about aesthetics; preserving muscle mass … Read more
Sixty percent. That’s the average amount of weight regained by individuals after discontinuing GLP-1 receptor agonist medications, according to recent analyses. While seemingly discouraging, this figure masks a more nuanced reality: even with regain, patients typically retain roughly a quarter of the weight they initially lost. This suggests a fundamental shift in metabolic setpoint, but … Read more
Weight-Loss Drugs Under Scrutiny: Health Risks Rise as Demand Surges A growing wave of concerns is emerging surrounding the widespread use of weight-loss medications, including GLP-1 receptor agonists like semaglutide and tirzepatide. Reports from Brazil and beyond indicate potential serious side effects, from pancreatitis to manipulation of drug supplies, raising questions about the safety and … Read more